1
|
Risk of Myocardial Infarction in Patients Without Angiographic Coronary Artery Disease Compared With the General Population. Am J Cardiol 2020; 132:8-14. [PMID: 32773225 DOI: 10.1016/j.amjcard.2020.06.068] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/22/2020] [Revised: 06/25/2020] [Accepted: 06/30/2020] [Indexed: 11/20/2022]
Abstract
We examined the 10-year risk of myocardial infarction (MI) and death in patients without obstructive coronary artery disease (CAD) compared with the general population. We conducted a cohort study of every patient without obstructive CAD by coronary angiography (CAG) between 2003 and 2016 in Western Denmark. Patients were matched by gender and age with individuals from the general population of Western Denmark with no history of CAD. End points were MI and death. Ten-year risk differences in cumulative incidence proportions were computed, accounting for the competing risk of death in the case of MI. Unadjusted and adjusted incidence rate ratios (aIRRs) were estimated using conditional Poisson regression. We included 46,467 patients and 234,654 individuals from the general population. Median follow-up was 7.7 years. The 10-year cumulative incidence of MI was 2.40% (95% confidence interval [CI] 2.24 to 2.57) in patients without obstructive CAD in the CAG and 2.70% (95% CI 2.62 to 2.78) in the general population, with a reduced absolute 10-year risk (risk difference -0.30%, 95% CI -0.49 to -0.12) and a reduced aIRR (aIRR 0.70, 95% CI 0.63 to 0.77). Ten-year mortality was higher in patients without obstructive CAD in the CAG (21.44%, 95% CI 20.99 to 21.89) compared with the general population (17.25%, 95% CI 17.06 to 17.44). However, mortality rates were similar after adjustment (aIRR 1.00, 95% CI 0.96 to 1.02). In conclusion, the absence of obstructive CAD according to CAG is associated with a lower risk of MI than in the general population, and similar 10-year mortality.
Collapse
|
2
|
Abstract
PURPOSE OF REVIEW To summarize the scientific basis of CT derived fractional flow reserve (FFRCT) and present an updated review on the evidence from clinical trials and real-world observational data RECENT FINDINGS: In prospective multicenter studies of patients with stable coronary artery disease (CAD), FFRCT showed high diagnostic performance. More recently, FFRCT has advanced to the realm of clinical utility and real-world clinical practice with emerging data showing that FFRCT when compared to standard care is efficient in safely reducing downstream utilization of invasive coronary angiography (ICA), and costs, as well as improving the diagnostic yield of ICA. Moreover, FFRCT may broaden applicability of frontline coronary CTA testing to patients with high pre-test risk of CAD. Introducing FFRCT into clinical practice has the potential to significantly improve the management of patients with stable CAD. The optimal FFRCT testing interpretation strategy, as well as the relative cost-efficiency of FFRCT against standard noninvasive functional testing, need further investigation.
Collapse
|
3
|
Taylor CA, Gaur S, Leipsic J, Achenbach S, Berman DS, Jensen JM, Dey D, Bøtker HE, Kim HJ, Khem S, Wilk A, Zarins CK, Bezerra H, Lesser J, Ko B, Narula J, Ahmadi A, Øvrehus KA, St Goar F, De Bruyne B, Nørgaard BL. Effect of the ratio of coronary arterial lumen volume to left ventricle myocardial mass derived from coronary CT angiography on fractional flow reserve. J Cardiovasc Comput Tomogr 2017; 11:429-436. [PMID: 28789941 DOI: 10.1016/j.jcct.2017.08.001] [Citation(s) in RCA: 62] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/05/2017] [Revised: 06/14/2017] [Accepted: 08/01/2017] [Indexed: 01/29/2023]
Abstract
BACKGROUND We hypothesize that in patients with suspected coronary artery disease (CAD), lower values of the ratio of total epicardial coronary arterial lumen volume to left ventricular myocardial mass (V/M) result in lower fractional flow reserve (FFR). METHODS V/M was computed in 238 patients from the NXT trial who underwent coronary computed tomography angiography (CTA), quantitative coronary angiography (QCA) and FFR measurement in 438 vessels. Nitroglycerin was administered prior to CT, QCA and FFR acquisition. The V/M ratio was quantified on a patient-level from CT image data by segmenting the epicardial coronary arterial lumen volume (V) and the left ventricular myocardial mass (M). Calcified and noncalcified plaque volumes were quantified using semi-automated software. RESULTS The median value of V/M (18.57 mm3/g) was used to define equal groups of low and high V/M patients. Patients with low V/M had greater diameter stenosis by QCA, more plaque and lower FFR (0.80 ± 0.12 vs. 0.87 ± 0.08; P < 0.0001) than those with high V/M. A total of 365 vessels in 202 patients had QCA stenosis ≤50% and measured FFR. In these patients, those with low V/M had higher percent diameter stenosis by QCA, greater total plaque volume and lower FFR (0.81 ± 0.12 vs. 0.88 ± 0.07; P < 0.0001) than those with high V/M. In multivariate logistic regression analysis, V/M was an independent predictor of FFR ≤0.80 (all p-values < 0.001). CONCLUSIONS Patients with a low V/M ratio have lower FFR overall and in non-obstructive CAD, independent of plaque measures.
Collapse
Affiliation(s)
- Charles A Taylor
- HeartFlow, Inc., Redwood City, CA, USA; Department of Bioengineering, Stanford University, Stanford, CA, USA.
| | - Sara Gaur
- Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
| | - Jonathon Leipsic
- Department of Radiology and Division of Cardiology, St. Paul's Hospital, Vancouver, British Columbia, Canada
| | | | - Daniel S Berman
- Department of Cardiology, Cedars Sinai Hospital, Los Angeles, CA, USA
| | - Jesper M Jensen
- Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
| | - Damini Dey
- Department of Cardiology, Cedars Sinai Hospital, Los Angeles, CA, USA
| | - Hans Erik Bøtker
- Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
| | | | | | - Alan Wilk
- HeartFlow, Inc., Redwood City, CA, USA
| | | | - Hiram Bezerra
- Department of Cardiology, Harrington Heart and Vascular Institute, University Hospitals Cleveland, Ohio, USA
| | - John Lesser
- Minneapolis Heart Institute, Minneapolis, MN, USA
| | - Brian Ko
- Monash Heart, Monash Medical Center and Monash University, Victoria, Australia
| | - Jagat Narula
- Department of Cardiology, Mount Sinai Hospital, New York, NY, USA
| | - Amir Ahmadi
- Department of Cardiology, Mount Sinai Hospital, New York, NY, USA
| | - Kristian A Øvrehus
- Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
| | - Fred St Goar
- Department of Cardiology, El Camino Hospital, Mountain View, CA, USA
| | | | - Bjarne L Nørgaard
- Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
| |
Collapse
|
4
|
Turner MC. High-risk plaque in patients with near normal coronary angiograms. Echocardiography 2016; 33:1762-1764. [DOI: 10.1111/echo.13361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Affiliation(s)
- Michael C. Turner
- Cardiovascular Specialists of Southwest Louisiana; Lake Charles Louisiana
| |
Collapse
|
6
|
How much evidence is in a case report? A road trip of scientific evidence, including skeptics, Ockham's razor, Hume's Fork, and Karl R. Popper. J Cardiovasc Comput Tomogr 2015; 9:267-9. [PMID: 26088377 DOI: 10.1016/j.jcct.2015.05.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/12/2015] [Accepted: 05/12/2015] [Indexed: 11/24/2022]
|